[go: up one dir, main page]

AT305288B - Verfahren zur Herstellung neuer 1-substituierter Tetrahydro-2-(1H)pyrimidone - Google Patents

Verfahren zur Herstellung neuer 1-substituierter Tetrahydro-2-(1H)pyrimidone

Info

Publication number
AT305288B
AT305288B AT194271A AT194271A AT305288B AT 305288 B AT305288 B AT 305288B AT 194271 A AT194271 A AT 194271A AT 194271 A AT194271 A AT 194271A AT 305288 B AT305288 B AT 305288B
Authority
AT
Austria
Prior art keywords
pyrimidones
preparation
new
substituted tetrahydro
tetrahydro
Prior art date
Application number
AT194271A
Other languages
English (en)
Original Assignee
Norwich Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norwich Pharma Co filed Critical Norwich Pharma Co
Application granted granted Critical
Publication of AT305288B publication Critical patent/AT305288B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/06Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D239/08Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms directly attached in position 2
    • C07D239/10Oxygen or sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/34One oxygen atom
    • C07D239/36One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Joining Of Building Structures In Genera (AREA)
  • Indole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT194271A 1970-03-05 1971-03-05 Verfahren zur Herstellung neuer 1-substituierter Tetrahydro-2-(1H)pyrimidone AT305288B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1698270A 1970-03-05 1970-03-05

Publications (1)

Publication Number Publication Date
AT305288B true AT305288B (de) 1973-02-26

Family

ID=21780073

Family Applications (1)

Application Number Title Priority Date Filing Date
AT194271A AT305288B (de) 1970-03-05 1971-03-05 Verfahren zur Herstellung neuer 1-substituierter Tetrahydro-2-(1H)pyrimidone

Country Status (14)

Country Link
US (1) US3681349A (de)
AT (1) AT305288B (de)
BE (1) BE763745A (de)
CH (1) CH555343A (de)
DE (1) DE2110445C3 (de)
DK (1) DK127427B (de)
ES (1) ES388780A1 (de)
FR (1) FR2085673B1 (de)
GB (1) GB1294626A (de)
IL (1) IL36189A0 (de)
NL (1) NL7102519A (de)
NO (1) NO130728C (de)
SE (1) SE376420B (de)
ZA (1) ZA71928B (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL39003A (en) * 1971-03-25 1975-02-10 Morton Norwich Products Inc 1-(substituted benzyl)tetrahydro-2-(1h)-pyrimidones and their preparation
US3957785A (en) * 1971-12-02 1976-05-18 Societa' Farmaceutici Italia S.P.A. Bβ-Pyrimidino-aminomethyl-10α-ergoline and 10α-methoxyergoline derivatives
US3956325A (en) * 1974-01-21 1976-05-11 Smithkline Corporation 5-Heterocyclic-1,2,3,6-tetrahydro-4(5H) pyrimidinone
US4003900A (en) * 1976-03-11 1977-01-18 Morton-Norwich Products, Inc. 1-Benzyl-5-chloro-2-(1H)-pyrimidone
US4002627A (en) * 1976-03-26 1977-01-11 Morton-Norwich Products, Inc. 1-Benzyl-3-methyl-3,4,5,6-tetrahydro-2(1H) pyrimidone
US4052399A (en) * 1976-09-13 1977-10-04 Morton-Norwich Products, Inc. 1-[2-(Hexahydro-1H-azepino)ethyl]-2(1H)pyrimidone dihydrochloride
US4052400A (en) * 1976-10-29 1977-10-04 Morton-Norwich Products, Inc. Hypertensive 1-substituted 2(1h)-pyrimidones
US8835426B2 (en) * 2007-02-26 2014-09-16 Vitae Pharmaceuticals, Inc. Cyclic urea and carbamate inhibitors of 11β-hydroxysteroid dehydrogenase 1
EP2183228B1 (de) * 2007-07-26 2014-08-20 Vitae Pharmaceuticals, Inc. ZYKLISCHE 11ß-HYDROXYSTEROID-DEHYDROGENASE-1-HEMMER
AR069207A1 (es) * 2007-11-07 2010-01-06 Vitae Pharmaceuticals Inc Ureas ciclicas como inhibidores de la 11 beta - hidroxi-esteroide deshidrogenasa 1
CA2708303A1 (en) 2007-12-11 2009-06-18 Vitae Pharmaceuticals, Inc. Cyclic urea inhibitors of 11.beta.-hydroxysteroid dehydrogenase 1
TW200934490A (en) * 2008-01-07 2009-08-16 Vitae Pharmaceuticals Inc Lactam inhibitors of 11 &abgr;-hydroxysteroid dehydrogenase 1
WO2009094169A1 (en) 2008-01-24 2009-07-30 Vitae Pharmaceuticals, Inc. Cyclic carbazate and semicarbazide inhibitors of 11beta-hydroxysteroid dehydrogenase 1
CA2714532A1 (en) * 2008-02-11 2009-08-20 Vitae Pharmaceuticals, Inc. 1,3-oxazepan-2-one and 1,3-diazepan-2-one inhibitors of 11.beta.-hydroxysteroid dehydrogenase 1
CA2715290A1 (en) * 2008-02-15 2009-08-20 Vitae Pharmaceuticals, Inc. Inhibitors of 11beta-hydroxysteroid dehydrogenase 1
JP5538356B2 (ja) * 2008-03-18 2014-07-02 ヴァイティー ファーマシューティカルズ,インコーポレイテッド 11β−ヒドロキシステロイドデヒドロゲナーゼ1型の阻害剤
TW200946520A (en) * 2008-05-01 2009-11-16 Vitae Pharmaceuticals Inc Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
CA2723039A1 (en) * 2008-05-01 2009-11-05 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
EP2291370B1 (de) * 2008-05-01 2013-11-27 Vitae Pharmaceuticals, Inc. Cyclische inhibitoren von 11beta-hydroxysteroiddehydrogenase 1
WO2009134384A1 (en) * 2008-05-01 2009-11-05 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
KR20110050459A (ko) * 2008-07-25 2011-05-13 비타이 파마슈티컬즈, 인코포레이티드 11베타-하이드록시스테로이드 탈수소효소 1의 고리형 억제제
WO2010127237A2 (en) * 2009-04-30 2010-11-04 Boehringer Ingelheim International Gmbh Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
CN102105454A (zh) 2008-07-25 2011-06-22 贝林格尔.英格海姆国际有限公司 合成1型11β-羟基类固醇脱氢酶的抑制剂
WO2010010157A2 (en) 2008-07-25 2010-01-28 Boehringer Ingelheim International Gmbh INHIBITORS OF 11beta-HYDROXYSTEROID DEHYDROGENASE 1
EP2393807B1 (de) 2009-02-04 2013-08-14 Boehringer Ingelheim International GmbH Zyklische 11beta-hydroxysteroid-dehydrogenase-1-hemmer
TW201039034A (en) * 2009-04-27 2010-11-01 Chunghwa Picture Tubes Ltd Pixel structure and the method of forming the same
MA33216B1 (fr) 2009-04-30 2012-04-02 Boehringer Ingelheim Int Inhibiteurs cycliques de la 11béta-hydroxysteroïde déshydrogénase 1
JP5656986B2 (ja) 2009-06-11 2015-01-21 ヴァイティー ファーマシューティカルズ,インコーポレイテッド 1,3−オキサジナン−2−オン構造に基づく11β−ヒドロキシステロイドデヒドロゲナーゼ1の環状阻害剤
WO2011002910A1 (en) 2009-07-01 2011-01-06 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
US8552212B2 (en) 2009-11-05 2013-10-08 Boehringer Ingelheim International Gmbh Chiral phosphorus ligands
AR078887A1 (es) * 2009-11-06 2011-12-07 Boehringer Ingelheim Int Derivados arilo y heteroarilcarbonilo de hexahidroindenopiridina y octahidrobenzoquinolina y composiciones farmaceuticas que los contienen.
US8648192B2 (en) 2010-05-26 2014-02-11 Boehringer Ingelheim International Gmbh 2-oxo-1,2-dihydropyridin-4-ylboronic acid derivatives
US8933072B2 (en) 2010-06-16 2015-01-13 Vitae Pharmaceuticals, Inc. Substituted 5-,6- and 7-membered heterocycles, medicaments containing such compounds, and their use
JP5813106B2 (ja) 2010-06-25 2015-11-17 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 代謝障害の処置のための11−β−HSD1のインヒビターとしてのアザスピロヘキサノン
KR20130137628A (ko) 2010-11-02 2013-12-17 베링거 인겔하임 인터내셔날 게엠베하 대사 장애를 치료하기 위한 약제학적 병용물
TWI537258B (zh) 2010-11-05 2016-06-11 百靈佳殷格翰國際股份有限公司 六氫茚并吡啶及八氫苯并喹啉之芳基-及雜環芳基羰基衍生物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE562987A (de) * 1956-12-05
DE1121617B (de) * 1959-05-26 1962-01-11 Huels Chemische Werke Ag Verfahren zur Herstellung von Tetrahydropyrimidin-2-onderivaten
DE1545601A1 (de) * 1965-07-22 1969-08-07 Basf Ag Verfahren zur Herstellung von Hexahydro-pyrimidinderivaten
DE1670368A1 (de) * 1966-07-16 1970-11-05 Cassella Farbwerke Mainkur Ag Verfahren zur Herstellung aralkylsubstituierter Lactame und Cyclischer Harnstoffe
DE1670241A1 (de) * 1967-07-01 1971-01-28 Basf Ag Verfahren zur Herstellung von 2-Oxohexahydropyrimidinen

Also Published As

Publication number Publication date
DK127427B (da) 1973-11-05
SE376420B (de) 1975-05-26
BE763745A (fr) 1971-09-03
ES388780A1 (es) 1975-03-01
NL7102519A (de) 1971-09-07
FR2085673B1 (de) 1974-09-06
CH555343A (de) 1974-10-31
DE2110445C3 (de) 1975-05-28
IL36189A0 (en) 1971-04-28
FR2085673A1 (de) 1971-12-31
ZA71928B (en) 1972-09-27
US3681349A (en) 1972-08-01
DE2110445B2 (de) 1974-10-10
GB1294626A (en) 1972-11-01
DE2110445A1 (de) 1971-11-04
NO130728C (de) 1975-01-29
NO130728B (de) 1974-10-21

Similar Documents

Publication Publication Date Title
AT305288B (de) Verfahren zur Herstellung neuer 1-substituierter Tetrahydro-2-(1H)pyrimidone
CH531000A (de) Verfahren zur Herstellung neuer Benzocycloheptathiophene
CH530415A (de) Verfahren zur Herstellung von Pyrimidinderivaten
AT317229B (de) Verfahren zur Herstellung von neuen 4-Hydroxy-6-aryl-bzw. 6-heteroarylpyrimidinen
AT311351B (de) Verfahren zur Herstellung neuer 1-Isopropyl-4-phenyl-2(1H)-chinazolinone
AT306731B (de) Verfahren zur Herstellung neuer 4-Phenyl-2(1H)-chinazolinone
DK130115B (da) Analogifremgangsmåde til fremstilling af 1-substituerede 2(1H)-quinazolinoner.
CH507959A (de) Verfahren zur Herstellung neuer Pyrimidin-Derivate
CH515911A (de) Verfahren zur Herstellung von 3,4-Dihydro-4-phenyl-2(1H)-chinazolinonen
AT306046B (de) Verfahren zur Herstellung von neuen semicyclischen Amidinen
AT330143B (de) Verfahren zur herstellung von 2-substituierten 4-hydroxy -2- cyclopenten -1- onen
CH555816A (de) Verfahren zur herstellung von acetamid-s-oxid-verbindungen.
CH553758A (de) Verfahren zur herstellung von azidosulfonylcarbanilaten.
CH533120A (de) Verfahren zur Herstellung von Pyrimidinderivaten
CH533633A (de) Verfahren zur Herstellung neuer Phenanthrotriazolylderivate
AT301562B (de) Verfahren zur Herstellung von neuen 2,6-Dimorpholino-8-alkanolamino-pyrimido[5,4-d]pyrimidinen
CH514596A (de) Verfahren zur Herstellung von 4-Phenylchinazolin-2(1H)-thionen
CH557371A (de) Verfahren zur herstellung von substituierten 5-hydroxyoenanthsaeurelactonen.
AT308714B (de) Verfahren zur Herstellung von Hydroxypivalaldehyd
AT308106B (de) Verfahren zur Herstellung neuer 2-(4-Oxo-4H-1-benzopyran-7-yl)-oxy-isobuttersäure-Derivate
CH557793A (de) Verfahren zur herstellung von sebacinsaeurediestern.
CH514603A (de) Verfahren zur Herstellung neuer 4-Phenyl-2(1H)-chinazolinone
AT326665B (de) Verfahren zur herstellung von 2,4-diamino-5-(3,4,5-trimethoxybenzyl)-pyrimidin
CH558345A (de) Verfahren zur herstellung von 3(beta)-alkoxymethoxy-14-hydroxy-5(beta)-card-20(22)-enoliden.
CH523262A (de) Verfahren zur Herstellung von Pyrimidinderivaten